MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The alteration of GABA and glutamate in Parkinson’s disease is related to motor executive dysfunction: a 7T-MRS study

D. Su, N. Wei, R. Yan, Z. Zhang, T. Feng (Beijing, China)

Meeting: 2024 International Congress

Abstract Number: 1064

Keywords: Magnetic resonance imaging(MRI), Parkinson’s, Resting brain metabolism

Category: Parkinson's Disease: Neuroimaging

Objective: To explore the possible metabolic alterations of primary motor cortices (M1) of Parkinson’s disease (PD) patients and prodromal PD using 7T proton magnetic resonance spectroscopy (MRS).

Background: Glutamate and GABAergic dysregulation exacerbates excitotoxicity and disrupts motor circuitry, both contributing to PD pathology. The primary motor cortex (M1) is critical for motor executive function. Understanding how GABA and glutamate dysregulation in M1 contribute to PD motor executive dysfunction is crucial for targeted therapeutic development to mitigate disease progression. Utilizing 7T MRS offers an advantage in quantifying GABA and glutamate levels, aiding in the precise evaluation of neurotransmitter alterations in PD.

Method: We included 17 PD patients, 16 HCs and 10 patients with idiopathic rapid eye movement sleep behavior disorder (iRBD). 7T MRS data were acquired using a stimulated echo acquisition mode (STEAM) localization technique in M1. Metabolites including glutamate (Glu), gamma-aminobutyric acid (GABA), N-acetyl aspartate (NAA), phosphocholine (PCho), and glycerophosphocholine (GPC) concentrations were quantified by using LCModel software and then corrected for the partial volume effect of cerebrospinal fluid.

Results: The results demonstrated that compared with HC, GABA of the M1 cortex was significantly lower in PD and iRBD patients (PD vs HC: 1.00±0.60 vs 1.66±0.49, p=0.003; iRBD vs HC: 1.04±0.20, p=0.005). The absolute and actual GABA concentrations in the M1 cortex of PD patients showed a decreasing trend compared to iRBD, although the difference did not reach statistically significant. The concentration of PCho+GPC in iRBD significantly decreased compared to HC (iRBD vs HC: 2.30 ± 0.25 vs 2.78 ± 0.53, p=0.045) and PD (PD vs prodromal phase PD: 2.94 ± 0.59 vs 2.30 ± 0.25, p=0.009). The concentration of Glu was significantly positively correlated with the total UPDRS III score (r=0.53, p=0.037) and UPDRS III score of the more affected side (r=0.56, p=0.025). The absolute concentrations of NAA+NAAG (r=0.58, p=0.019) and Glu+Gln (r=0.52, p=0.037) were significantly positively correlated with the total UPDRS III score.

Conclusion: These findings may shed a light on the metabolic mechanism of PD motor executive dysfunction. The motor deficits may be related to the disorder of neurotransmitter transmission and brain energy metabolism.

To cite this abstract in AMA style:

D. Su, N. Wei, R. Yan, Z. Zhang, T. Feng. The alteration of GABA and glutamate in Parkinson’s disease is related to motor executive dysfunction: a 7T-MRS study [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/the-alteration-of-gaba-and-glutamate-in-parkinsons-disease-is-related-to-motor-executive-dysfunction-a-7t-mrs-study/. Accessed July 4, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-alteration-of-gaba-and-glutamate-in-parkinsons-disease-is-related-to-motor-executive-dysfunction-a-7t-mrs-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley